|
Click here to return to main
plasmids page |
|
|
|
|||
|
|
|
|
||||
|
Papillomaviruses |
Paper
Name |
Reference |
Lab
Name |
Distribute? |
Resistance |
Notes |
|
BPV1 |
[1] |
pXLº |
kan |
Bicistronic, too large to self-package* |
||
|
|
|
|
|
|
|
|
|
CRPV |
[2] |
p¢LLw |
yes |
amp |
Bicistronic, too large to self-package* |
|
|
|
|
|
|
|
|
|
|
HPV1 |
unpublished |
p1LLw |
not yet |
amp |
HPV1 gives poor L1 yield and HPV1 pseudovirus is poorly
infectious |
|
|
|
|
|
|
|
|
|
|
HPV2 |
unpublished |
p2LLw |
yes |
amp |
This plasmid produces good yields of HPV2 prototype L1/L2
particles that have essentially no detectable infectivity on any tested cell
line. |
|
|
|
pRŠLw |
|
|
This variant (EF362755) HPV2 L1 produces pseudoviruses
with detectable (but still extremely poor) infectious titer. Harvest 72h
post-transfection |
||
|
|
[3] |
pŠº |
|
|
HPV2 L2 expression plasmid |
|
|
|
|
|
|
|
|
|
|
HPV5 |
[5] |
p5LLw |
yes |
amp |
Bicistronic, too large to self-package*. HPV5 has high particle to infectivity
ratio on many cell types |
|
|
|
|
|
|
|
|
|
|
HPV6 |
[6] |
p6LLw2 |
yes |
amp |
orignal
"p6sheLL" had an unexpected duplication in the backbone due to a
cloning error. The duplication
was repaired in p6sheLLr. p6sheLL and p6sheLLr give essentially identical titer
yields for HPV6 pseudovirus production. |
|
|
|
|
|
|
|
|
|
|
HPV11 |
[7] |
p11Lw |
yes,
MŸller MTA |
kan |
Titer of HPV11 pseudovirus is very poor. Requires MŸller MTA. |
|
|
|
[8] |
p11ºw |
yes,
MŸller MTA |
kan |
|
|
|
|
|
|
|
|
|
|
|
HPV16 |
p16LLw |
yes,
MŸller MTA |
amp |
Replaces pXuLL. Bicistronic, too large to
self-package*. Requires MŸller
MTA. |
||
|
|
phŸLº, frankenvirus |
yes,
MŸller MTA |
zeo |
Synthetic HPV capable of self-packaging. Suitable for infectious
amplification in 293TT cells.
This plasmid is prone to collapse* |
||
|
|
|
|
|
|
|
|
|
HPV18 |
p18LLw |
amp |
Bicistronic, too large to self-package* |
|||
|
|
|
|
|
|
|
|
|
HPV27 |
Senger et al |
[3] |
|
|
|
|
|
|
|
|
|
|
|
|
|
HPV31 |
p31LLw |
yes,
Kanda MTA |
amp |
Bicistronic, too large to self-package*. Requires Kanda MTA. |
||
|
|
|
|
|
|
|
|
|
HPV35 |
[14] |
5psh35F |
yes, contact
Simon Beddows |
amp |
HPV35 L1 and L2 genes codon optimised
for mammalian expression. Requires HPA UK MTA |
|
|
|
|
|
|
|
|
|
|
HPV38 |
Faust et al |
[15] |
|
Faust et al |
|
|
|
|
|
|
|
|
|
|
|
HPV39 |
[14] |
39pshC |
yes, contact
Simon Beddows |
amp |
HPV35 L1 and L2 genes codon optimised
for mammalian expression. Requires HPA UK MTA |
|
|
|
|
|
|
|
|
|
|
HPV45 |
p45LLw |
amp |
Bicistronic, too large to self-package* |
|||
|
|
|
|
|
|
|
|
|
HPV52 |
[16] |
p52LLw |
yes |
amp |
Bicistronic, too large to self-package*. Poor titer yield. Requires Kanda MTA. |
|
|
|
|
|
|
|
|
|
|
HPV57 |
Senger et al |
[3] |
|
Senger et al |
|
|
|
|
|
|
|
|
|
|
|
HPV58 |
[13] |
p58LLw |
yes,
Kanda MTA |
amp |
Bicistronic, too large to self-package*. Requires Kanda MTA. |
|
|
|
|
|
|
|
|
|
|
HPV59 |
[14] |
59pshB |
yes, contact
Simon Beddows |
amp |
HPV35 L1 and L2 genes codon optimised
for mammalian expression. Requires HPA UK MTA |
|
|
|
|
|
|
|
|
|
|
MusPV1 |
unpublished |
pMuLLw |
amp |
Mammalian expression plasmid with codon modified L1 and
L2 genes of Mus musculus
papillomavirus type 1* |
||
|
|
pMusPV |
zeo |
Synthetic
Mus musculus
papillomavirus type 1 clone |
|||
|
|
|
|
|
|
|
|
|
Polyomaviruses |
|
|
|
|
|
|
|
BKV-I |
[19] |
|
Nakanishi et al |
|
VP1/2/3 packaging plasmid for BKV serogroup I (isolate
KOM5) reporter vectors |
|
|
|
Unpublished |
pIaw |
Yes |
zeo |
Codon modified BKV genotype Ia VP1 expression plasmid |
|
|
|
|
|
|
|
|
|
|
BKV-IV |
[20] |
pwB |
zeo |
VP1 based on BKV serogroup IV isolate A-66H [21] |
||
|
|
[20] |
pwB2b |
zeo |
BKV-IV VP1/VP2 dual expression plasmid |
||
|
|
[20] |
pwB3b |
zeo |
BKV-IV VP1/VP3 dual expression plasmid |
||
|
|
[20] |
ph2b |
zeo |
BKV-IV VP2 expression plasmid |
||
|
|
[20] |
ph3b |
zeo |
BKV-IV VP3 expression plasmid |
||
|
BKV variants |
MS in prep |
Various |
Yes |
zeo |
Codon modified VP1 ORFs from various BKV genotypes |
|
|
|
|
|
|
|
|
|
|
HPyV6 |
[22] |
pe1D |
zeo |
Reference clone of human polyomavirus 6 |
||
|
|
[22] |
pe1VP1 |
zeo |
Human polyomavirus 6 VP1 expression construct |
||
|
|
|
|
|
|
|
|
|
HPyV7 |
[22] |
pe2S |
zeo |
Reference clone of human polyomavirus 7 |
||
|
|
[22] |
pe2VP1 |
zeo |
Human polyomavirus 7 VP1 expression construct |
||
|
|
|
|
|
|
|
|
|
HPyV10 |
p10ww |
yes |
zeo |
Reference clone of human polyomavirus 10 (MWPyV) |
||
|
|
|
|
|
|
|
|
|
MCV |
[22] |
pMCV-L |
kan |
Reference clone of wild-type MCV from healthy skin |
||
|
|
[22] |
p17A |
yes |
zeo |
wt MCV clone. Seems to replicate a
bit better than R71a [25] |
|
|
|
unpublished |
p16A |
yes |
zeo |
MCV–R17a
chimera with NCRR of Asian isolate MCV-16b |
|
|
|
[26] |
pwM |
zeo |
Merkel cell polyomavirus (MCV) VP1 expression construct |
||
|
|
[26] |
ph2m |
zeo |
MCV VP2 expression construct |
||
|
|
[27] |
pwM2m |
yes |
zeo |
MCV VP1/VP2 dual expression (VP2 expression relatively
weak) |
|
|
|
unpublished |
pMmw |
yes |
amp |
MCV VP1/VP2 expression, too big to self-package* |
|
|
|
|
|
|
|
|
|
|
MPyV |
[26] |
pwP |
zeo |
Mouse polyomavirus (MPyV) VP1 expression construct |
||
|
|
[26] |
ph2p |
zeo |
MPyV VP2 expression construct |
||
|
|
[26] |
ph3p |
zeo |
MPyV VP3 expression construct |
||
|
|
|
|
|
|
|
|
|
*Plasmids >10kb can be unstable in E. coli. |
|
|
|
|
||
|
Growing bacterial starter cultures at 30¼C and/or using
Invitrogen STBL2 or Stratagene XL10-Gold bacteria
may decrease the risk of plasmid collapse. |
||||||